Abstract
It was 11 March 2020 when the World Health Organization (WHO) declared the name COVID-19 for coronavirus disease and also described it as a pandemic. Till that day 118,000 cases were confirmed of pneumonia with breathing problem throughout the world. At the start of New Year when COVID-19 came into knowledge a few days later, the gene sequencing of the virus was revealed. Today the number of confirmed cases is scary, i.e. 9,472,473 in the whole world and 484,236 deaths have been recorded by WHO till 26 June 2020. WHO's global risk assessment is very high [1]. The report is enlightening the lessons learned by India from the highly affected countries.
Keywords: Death rate, different scenario, fight against COVID-19, remedial action, WHO, risk assessment.
Current Signal Transduction Therapy
Title:How India Fights with COVID-19 Learning from Highly Affected Countries
Volume: 16 Issue: 3
Author(s): Pooja Sharma and Karan Veer*
Affiliation:
- Department of Instrumentation & Control Engineering, Dr. B.R. Ambedkar National Institute of Technology, Jalandhar 144011,India
Keywords: Death rate, different scenario, fight against COVID-19, remedial action, WHO, risk assessment.
Abstract: It was 11 March 2020 when the World Health Organization (WHO) declared the name COVID-19 for coronavirus disease and also described it as a pandemic. Till that day 118,000 cases were confirmed of pneumonia with breathing problem throughout the world. At the start of New Year when COVID-19 came into knowledge a few days later, the gene sequencing of the virus was revealed. Today the number of confirmed cases is scary, i.e. 9,472,473 in the whole world and 484,236 deaths have been recorded by WHO till 26 June 2020. WHO's global risk assessment is very high [1]. The report is enlightening the lessons learned by India from the highly affected countries.
Export Options
About this article
Cite this article as:
Sharma Pooja and Veer Karan *, How India Fights with COVID-19 Learning from Highly Affected Countries, Current Signal Transduction Therapy 2021; 16 (3) . https://dx.doi.org/10.2174/1574362415999200807154418
DOI https://dx.doi.org/10.2174/1574362415999200807154418 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
COVID-19 Pandemic: Age and Temperature Related Effects
Coronaviruses Discovery of Potential Inhibitors of the Receptor-binding Domain (RBD) of Pandemic Disease-causing SARS-CoV-2 Spike Glycoprotein from Triphala Through Molecular Docking
Current Chinese Chemistry Potential Candidates against COVID-19 Targeting RNA-Dependent RNA Polymerase: A Comprehensive Review
Current Pharmaceutical Biotechnology Remdesivir (GS-5734) for COVID-19 Treatment: Past and Recent Updates
Coronaviruses Learning from Metabolic Networks: Current Trends and Future Directions for Precision Medicine
Current Medicinal Chemistry Self-Protection of Medical Workers in Traditional Hospitals and Clinics Against SARS-CoV-2 Infection
Coronaviruses Synthesis and Biological Evaluation of Some New N4-Aryl Substituted 5-Chloroisatin-3-thiosemicarbazones
Medicinal Chemistry Properties of Ethnomedicinal Plants and Their Bioactive Compounds: Possible Use for COVID-19 Prevention and Treatment
Current Pharmaceutical Design <i>In Silico</i> Modeling of Small Molecule Carboxamides as Inhibitors of SARS-CoV 3CL Protease: An Approach Towards Combating COVID-19
Combinatorial Chemistry & High Throughput Screening Recent Patents on Cell Cycle Regulatory Proteins
Recent Patents on Biotechnology The Hidden Impact of COVID-19 on Sexual and Reproductive Health and Rights of Women in India
Current Women`s Health Reviews Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part II)
Current Pharmaceutical Design Recent Advances in Natural Products with Antiviral Activities
Mini-Reviews in Medicinal Chemistry Aryl/heteroaryl Substituted Celecoxib Derivatives as COX-2 Inhibitors: Synthesis, Anti-inflammatory Activity and Molecular Docking Studies
Medicinal Chemistry Role of Pulmonary Ultrasound in COVID-19 Pandemics
Current Respiratory Medicine Reviews Occupational Exposure and Respiratory Tract Infections –At Risk Workers in the International Context
Current Respiratory Medicine Reviews Is There Any Role of IL-6 Inhibition in COVID-19?
Coronaviruses Predicting the Activity of ACE Inhibitory Peptides with a Novel Mode of Pseudo Amino Acid Composition
Protein & Peptide Letters A Mini-review of Computational Approaches to Predict Functions and Findings of Novel Micro Peptides
Current Bioinformatics <i>In-silico</i> Analysis of Angiotensin-converting Enzyme 2 (ACE2) of Livestock, Pet and Poultry Animals to Determine its Susceptibility to SARS–CoV- 2 Infection
Combinatorial Chemistry & High Throughput Screening